Leila Alland
Director/Board Member presso ABEONA THERAPEUTICS INC.
Patrimonio netto: 570 545 $ in data 31/03/2024
Profilo
Leila Alland is an Independent Director at Abeona Therapeutics, Inc., a Director at Jubilant Therapeutics, Inc., and a Non-Executive Director at Radiopharm Theranostics Ltd.
She previously worked as a Director at Cytovia Therapeutics, Inc., Chief Medical Officer at Affimed NV, Vice President & Head-Oncology at AstraZeneca LP, and Chief Medical Officer at Tarveda Therapeutics, Inc. She also held the position of Assistant Professor-Pediatrics at Albert Einstein College of Medicine, Inc. and Chief Medical Officer at PMV Pharmaceuticals, Inc. Alland received her undergraduate degree from the University of Pennsylvania and her doctorate from New York University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/03/2024 | 67 931 ( 0.25% ) | 492 500 $ | 31/03/2024 | |
| 15/09/2023 | 45 909 ( 0.09% ) | 78 045 $ | 31/03/2024 |
Posizioni attive di Leila Alland
| Società | Posizione | Inizio |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 19/04/2021 |
| RADIOPHARM THERANOSTICS LIMITED | Director/Board Member | 06/06/2022 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Director/Board Member | 16/08/2021 |
Precedenti posizioni note di Leila Alland
| Società | Posizione | Fine |
|---|---|---|
| AFFIMED N.V. | Chief Tech/Sci/R&D Officer | 30/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Chief Tech/Sci/R&D Officer | 01/03/2018 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Corporate Officer/Principal | 01/12/2015 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 01/06/2000 |
| PMV PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Leila Alland
| University of Pennsylvania | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| AFFIMED N.V. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Aziende private | 4 |
|---|---|
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Health Technology |
- Borsa valori
- Insiders
- Leila Alland
